Product Reports Resources Pricing Login Book a demo

Health

Europe’s health companies are worth $703B and raised about a third as much venture capital as US peers in 2025

By Yoram Wijngaarde and Dealroom Next-Gen API

Europe’s venture-backed health companies are worth $703B, 7.5 times their 2015 value. New money is going into prevention and consumer health, from smart rings to full-body scans, and into AI drug discovery. European health startups raise as many small rounds as American ones, but the US raises 7 times as many rounds of $100M or more, and six of the nine largest recent sales went to buyers outside Europe. Italy raises less health venture capital per person than any of 13 European peers.